Dr. Keda Yu 余科达
Chief Physician
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radical mastectomy, breast-conserving surgery, and reconstruction using latissimus dorsi flaps or implants. Management of locally advanced breast cancer and postoperative comprehensive therapy.
Dr. Yu holds a PhD from Fudan University Shanghai Medical College and serves as Deputy Director of Breast Surgery. With 17 years of experience, Dr. Yu completed a one-year visiting scholar position at Baylor College of Medicine Methodist Hospital Cancer Center in the US and collaborated with centers in the UK, Germany, France, and Japan.
Professional roles
- Member, National Excellent Young Talents Program
- Shanghai Outstanding Academic Leader
- Recipient, Shanghai Health System Excellent Young Scholar Plan
- Recipient, Shanghai Shuguang Talent Program
Name order: in Chinese the family name comes first (Yu Keda). Papers usually list the name as Keda Yu or Yu K.
Selected publications
109 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Rep Med, 2026 (senior author): Spatial proteogenomic profiling uncovers sensitization strategies for antibody-drug conjugate in HER2-positive breast cancer. PubMed 42594874
- Protein Cell, 2026 (senior author): Multi-omics analysis reveals comprehensive aberrant protein and phosphorylation characteristics in breast cancer and paired metastatic lymph nodes. PubMed 41527309
- Exp Hematol Oncol, 2026 (senior author): Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities. PubMed 42001172
- Proc Natl Acad Sci U S A, 2025 (senior author): SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer. PubMed 40228127
- Exp Hematol Oncol, 2025 (senior author): RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. PubMed 40176140
- Lancet Reg Health West Pac, 2025 (senior author): Immunotherapy and its racial specificity for breast cancer treatment in Asia: a narrative review. PubMed 40443538
- Fundam Res, 2025 (senior author): Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification. PubMed 40242534
- Cancer Lett, 2025 (senior author): Unraveling the peripheral nervous System's role in tumor: A Double-edged Sword. PubMed 39793755
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion